Skip to main content
Top
Published in: Journal of Translational Medicine 1/2017

Open Access 01-12-2017 | Research

Prostate cancer small non-coding RNA transcriptome in Arabs

Authors: Jingxuan Shan, Khalid Al-Rumaihi, Karim Chouchane, Issam Al-Bozom, Danny Rabah, Karim Farhat, Lotfi Chouchane

Published in: Journal of Translational Medicine | Issue 1/2017

Login to get access

Abstract

Background

Prostate cancer (PCa) is a complex disorder resulting from the combined effects of multiple environmental and genetic factors. Small non-coding RNAs (sRNAs), particularly microRNAs (miRNAs), regulate several cellular processes and have an important role in many human malignancies including PCa. We assessed the sRNA profiles associated with PCa in Arabs, a population that has rarely been studied.

Methods

We used next generation sequencing technology to obtain the entire sRNA transcriptome of primary prostate tumor formalin-fixed paraffin-embedded tissues, and their paired non-tumor tissues, collected from Bedouin patients (Qatari and Saudi). The miRNA and the target gene expression were evaluated by real-time quantitative PCR. miRNA KEGG pathway and miRNA target genes were subsequently analyzed by starBase and TargetScan software.

Results

Different expression patterns of several sRNA and miRNA editing were revealed between PCa tumor and their paired non-tumor tissues. Our study identified four miRNAs that are strongly associated with prostate cancer, which have not been reported previously. Differentially expressed miRNAs significantly affect various biological pathways, such as cell cycle, endocytosis, adherence junction and pathways involved in cancer. Prediction of potential targets for the identified miRNAs indicates the overexpression of KRAS, BCL2 and down-regulation of PTEN in PCa tumor tissues.

Conclusion

These miRNAs, newly associated with prostate cancer, may represent not only markers for the increased risk of PCa in Arabs, but may also reflect the clinical and pathological diversity as well as the ethno-specific heterogeneity of prostate cancer.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.CrossRefPubMed
3.
go back to reference Salim EI, Moore MA, Al-Lawati JA, et al. Cancer epidemiology and control in the Arab world-past, present and future. Asian Pac J Cancer Prev. 2009;10:3–16.PubMed Salim EI, Moore MA, Al-Lawati JA, et al. Cancer epidemiology and control in the Arab world-past, present and future. Asian Pac J Cancer Prev. 2009;10:3–16.PubMed
4.
go back to reference Young JL. Cancer incidence in the Middle East and Gulf cooperation council countries. Presented at the Middle East Cancer Consortium Steering Committee Meeting, Lyon, France; 2003. Young JL. Cancer incidence in the Middle East and Gulf cooperation council countries. Presented at the Middle East Cancer Consortium Steering Committee Meeting, Lyon, France; 2003.
5.
go back to reference Morgan R, Thornton S, El-Derery A, et al. Prostate cancer—what can be relevant from global populations? In: 2nd Pan Arab human genetics conference, Dubai, UAE; 2007. p. 63. Morgan R, Thornton S, El-Derery A, et al. Prostate cancer—what can be relevant from global populations? In: 2nd Pan Arab human genetics conference, Dubai, UAE; 2007. p. 63.
6.
go back to reference Page WF, Braun MM, Parrin AW, et al. Heredity and prostate cancer: a study of World War II veteran twins. Prostate. 1997;33:240–5.CrossRefPubMed Page WF, Braun MM, Parrin AW, et al. Heredity and prostate cancer: a study of World War II veteran twins. Prostate. 1997;33:240–5.CrossRefPubMed
7.
go back to reference Kehinde EO, Sheikh M, Mojimoniyi OA, et al. High serum prostate-specific antigen levels in the absence of prostate cancer in Middle-Eastern men: the clinician’s dilemma. BJU Int. 2003;91:618–22.CrossRefPubMed Kehinde EO, Sheikh M, Mojimoniyi OA, et al. High serum prostate-specific antigen levels in the absence of prostate cancer in Middle-Eastern men: the clinician’s dilemma. BJU Int. 2003;91:618–22.CrossRefPubMed
12.
go back to reference Mendell JT. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle. 2005;4:1179–84.CrossRefPubMed Mendell JT. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle. 2005;4:1179–84.CrossRefPubMed
13.
go back to reference Catto JW, Alcaraz A, Bjartell AS, et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol. 2011;59:671–81.CrossRefPubMed Catto JW, Alcaraz A, Bjartell AS, et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol. 2011;59:671–81.CrossRefPubMed
14.
go back to reference Hassan O, Ahmad A, Sethi S, Sarkar FH. Recent updates on the role of microRNAs in prostate cancer. J Hematol Oncol. 2012;14:5–9. Hassan O, Ahmad A, Sethi S, Sarkar FH. Recent updates on the role of microRNAs in prostate cancer. J Hematol Oncol. 2012;14:5–9.
16.
go back to reference Reis EM, Nakaya HI, Louro R, et al. Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer. Oncogene. 2004;23:6684–92.CrossRefPubMed Reis EM, Nakaya HI, Louro R, et al. Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer. Oncogene. 2004;23:6684–92.CrossRefPubMed
17.
go back to reference Dong XY, Rodriguez C, Guo P, et al. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet. 2008;17:1031–42.CrossRefPubMedPubMedCentral Dong XY, Rodriguez C, Guo P, et al. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet. 2008;17:1031–42.CrossRefPubMedPubMedCentral
18.
go back to reference Ender C, Krek A, Friedländer MR, et al. A human snoRNA with microRNA-like functions. Mol Cell. 2008;32:519–28.CrossRefPubMed Ender C, Krek A, Friedländer MR, et al. A human snoRNA with microRNA-like functions. Mol Cell. 2008;32:519–28.CrossRefPubMed
19.
20.
21.
go back to reference Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH. starBase: a database for exploring microRNA-mRNA interaction maps from argonaute CLIP-Seq and degradome-seq data. Nucleic Acids Res. 2011;39:D202–9.CrossRefPubMed Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH. starBase: a database for exploring microRNA-mRNA interaction maps from argonaute CLIP-Seq and degradome-seq data. Nucleic Acids Res. 2011;39:D202–9.CrossRefPubMed
22.
23.
go back to reference Yang W, Chendrimada TP, Wang Q, et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol. 2006;13:13–21.CrossRefPubMed Yang W, Chendrimada TP, Wang Q, et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol. 2006;13:13–21.CrossRefPubMed
25.
go back to reference Godfrey AC, Xu Z, Weinberg CR, et al. Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort. Breast Cancer Res. 2013;15:R42.CrossRefPubMedPubMedCentral Godfrey AC, Xu Z, Weinberg CR, et al. Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort. Breast Cancer Res. 2013;15:R42.CrossRefPubMedPubMedCentral
28.
go back to reference Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007;133:647–58.CrossRefPubMedPubMedCentral Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007;133:647–58.CrossRefPubMedPubMedCentral
29.
go back to reference Miao Y, Zheng W, Li N, Su Z, Zhao L, Zhou H, Jia L. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway. Sci Rep. 2017;7:41942.CrossRefPubMedPubMedCentral Miao Y, Zheng W, Li N, Su Z, Zhao L, Zhou H, Jia L. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway. Sci Rep. 2017;7:41942.CrossRefPubMedPubMedCentral
30.
go back to reference Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.CrossRefPubMed Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.CrossRefPubMed
31.
go back to reference Karube Y, Tanaka H, Osada H, et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 2005;96:111–5.CrossRefPubMed Karube Y, Tanaka H, Osada H, et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 2005;96:111–5.CrossRefPubMed
32.
go back to reference Pampalakis G, Diamandis EP, Katsaros D, Sotiropoulou G. Down-regulation of dicer expression in ovarian cancer tissues. Clin Biochem. 2010;43:324–7.CrossRefPubMed Pampalakis G, Diamandis EP, Katsaros D, Sotiropoulou G. Down-regulation of dicer expression in ovarian cancer tissues. Clin Biochem. 2010;43:324–7.CrossRefPubMed
33.
go back to reference Zhu DX, Fan L, Lu RN, et al. Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia. Cancer Sci. 2012;10:875–81.CrossRef Zhu DX, Fan L, Lu RN, et al. Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia. Cancer Sci. 2012;10:875–81.CrossRef
34.
go back to reference Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol RW, Dhir R. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol. 2006;169(5):1812–20.CrossRefPubMedPubMedCentral Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol RW, Dhir R. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol. 2006;169(5):1812–20.CrossRefPubMedPubMedCentral
35.
go back to reference Park JY. Promoter hypermethylation as a biomarker in prostate adenocarcinoma. Methods Mol Biol. 2015;1238:607–25.CrossRefPubMed Park JY. Promoter hypermethylation as a biomarker in prostate adenocarcinoma. Methods Mol Biol. 2015;1238:607–25.CrossRefPubMed
36.
go back to reference Moarii M, Boeva V, Vert JP, Reyal F. Changes in correlation between promoter methylation and gene expression in cancer. BMC Genom. 2015;16:873.CrossRef Moarii M, Boeva V, Vert JP, Reyal F. Changes in correlation between promoter methylation and gene expression in cancer. BMC Genom. 2015;16:873.CrossRef
37.
go back to reference Bhardwaj A, Srivastava SK, Khan MA, et al. Racial disparities in prostate cancer: a molecular perspective. Front Biosci (Landmark Ed). 2017;22:772–82.CrossRefPubMedPubMedCentral Bhardwaj A, Srivastava SK, Khan MA, et al. Racial disparities in prostate cancer: a molecular perspective. Front Biosci (Landmark Ed). 2017;22:772–82.CrossRefPubMedPubMedCentral
38.
go back to reference Ahmad A, Azim S, Zubair H, et al. Epigenetic basis of cancer health disparities: looking beyond genetic differences. Biochim Biophys Acta. 2017;1868:16–28.PubMed Ahmad A, Azim S, Zubair H, et al. Epigenetic basis of cancer health disparities: looking beyond genetic differences. Biochim Biophys Acta. 2017;1868:16–28.PubMed
39.
go back to reference Rawlings-Goss RA, Campbell MC, Tishkoff SA. Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers. BMC Med Genom. 2014;7:53.CrossRef Rawlings-Goss RA, Campbell MC, Tishkoff SA. Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers. BMC Med Genom. 2014;7:53.CrossRef
Metadata
Title
Prostate cancer small non-coding RNA transcriptome in Arabs
Authors
Jingxuan Shan
Khalid Al-Rumaihi
Karim Chouchane
Issam Al-Bozom
Danny Rabah
Karim Farhat
Lotfi Chouchane
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2017
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-017-1362-x

Other articles of this Issue 1/2017

Journal of Translational Medicine 1/2017 Go to the issue